• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗癌四唑桥联双核铂(II)配合物引起的巨型DNA中的特定构象变化:中等长度烷基取代基的影响最小。

Specific Conformational Change in Giant DNA Caused by Anticancer Tetrazolato-Bridged Dinuclear Platinum(II) Complexes: Middle-Length Alkyl Substituents Exhibit Minimum Effect.

作者信息

Komeda Seiji, Yoneyama Hiroki, Uemura Masako, Muramatsu Akira, Okamoto Naoto, Konishi Hiroaki, Takahashi Hiroyuki, Takagi Akimitsu, Fukuda Wakao, Imanaka Tadayuki, Kanbe Toshio, Harusawa Shinya, Yoshikawa Yuko, Yoshikawa Kenichi

机构信息

Faculty of Pharmaceutical Sciences, Suzuka University of Medical Science , Suzuka, Mie 513-8670, Japan.

Faculty of Pharmaceutical Sciences, Osaka University of Pharmaceutical Sciences , Takatsuki, Osaka 569-1094, Japan.

出版信息

Inorg Chem. 2017 Jan 17;56(2):802-811. doi: 10.1021/acs.inorgchem.6b02239. Epub 2017 Jan 3.

DOI:10.1021/acs.inorgchem.6b02239
PMID:28045514
Abstract

Derivatives of the highly antitumor-active compound [{cis-Pt(NH)}(μ-OH)(μ-tetrazolato-N2,N3)] (5-H-Y), which is a tetrazolato-bridged dinuclear platinum(II) complex, were prepared by substituting a linear alkyl chain moiety at C5 of the tetrazolate ring. The general formula for the derivatives is [{cis-Pt(NH)}(μ-OH)(μ-5-R-tetrazolato-N2,N3)], where R is (CH)CH and n = 0 to 8 (complexes 1-9). The cytotoxicity of complexes 1-4 in NCI-H460 human non-small-cell lung cancer cells decreased with increasing alkyl chain length, and those of complexes 5-9 increased with increasing alkyl chain length. That is, the in vitro cytotoxicity of complexes 1-9 was found to have a U-shaped association with alkyl chain length. This U-shaped association is attributable to the degree of intracellular accumulation. Although circular dichroism spectroscopic measurement indicated that complexes 1-9 induced comparable conformational changes in the secondary structure of DNA, the tetrazolato-bridged complexes induced different degrees of DNA compaction as revealed by a single DNA measurement with fluorescence microsopy, which also had a U-shaped association with alkyl chain length that matched the association observed for cytotoxicity. Complexes 7-9, which had alkyl chains long enough to confer surfactant-like properties to the complex, induced DNA compaction 20 or 1000 times more efficiently than 5-H-Y or spermidine. A single DNA measurement with transmission electron microscopy revealed that complex 8 formed large spherical self-assembled structures that induced DNA compaction with extremely high efficiency. This result suggests that these structures may play a role in the DNA compaction that was induced by the complexes with the longer alkyl chains. The derivatization with a linear alkyl chain produced a series of complexes with unique cellular accumulation and DNA conformational change profiles and a potentially useful means of developing next-generation platinum-based anticancer drugs. In addition, the markedly high ability of these complexes to induce DNA compaction and their high intracellular accumulation emphasized the difference in mechanism of action from platinum-based anticancer drugs.

摘要

具有高度抗肿瘤活性的化合物[{顺式-Pt(NH)}(μ-OH)(μ-四唑-N2,N3)](5-H-Y)是一种四唑桥联双核铂(II)配合物,通过在四唑环的C5位取代直链烷基链部分制备了其衍生物。衍生物的通式为[{顺式-Pt(NH)}(μ-OH)(μ-5-R-四唑-N2,N3)],其中R为(CH)CH且n = 0至8(配合物1-9)。配合物1-4在NCI-H460人非小细胞肺癌细胞中的细胞毒性随烷基链长度增加而降低,而配合物5-9的细胞毒性随烷基链长度增加而增加。也就是说,发现配合物1-9的体外细胞毒性与烷基链长度呈U形关联。这种U形关联归因于细胞内积累程度。尽管圆二色光谱测量表明配合物1-9在DNA二级结构中诱导了相当的构象变化,但如通过荧光显微镜的单DNA测量所揭示的,四唑桥联配合物诱导了不同程度的DNA压缩,其也与烷基链长度呈U形关联,这与细胞毒性观察到的关联相匹配。配合物7-9具有足够长的烷基链,赋予配合物类似表面活性剂的性质,其诱导DNA压缩的效率比5-H-Y或亚精胺高20倍或1000倍。透射电子显微镜的单DNA测量表明配合物8形成了大的球形自组装结构,其以极高的效率诱导DNA压缩。该结果表明这些结构可能在由具有较长烷基链的配合物诱导的DNA压缩中起作用。用直链烷基链进行衍生化产生了一系列具有独特细胞积累和DNA构象变化谱的配合物,是开发下一代铂基抗癌药物的潜在有用手段。此外,这些配合物诱导DNA压缩的显著高能力及其高细胞内积累强调了其作用机制与铂基抗癌药物的差异。

相似文献

1
Specific Conformational Change in Giant DNA Caused by Anticancer Tetrazolato-Bridged Dinuclear Platinum(II) Complexes: Middle-Length Alkyl Substituents Exhibit Minimum Effect.抗癌四唑桥联双核铂(II)配合物引起的巨型DNA中的特定构象变化:中等长度烷基取代基的影响最小。
Inorg Chem. 2017 Jan 17;56(2):802-811. doi: 10.1021/acs.inorgchem.6b02239. Epub 2017 Jan 3.
2
Synthesis of antitumor azolato-bridged dinuclear platinum(ii) complexes with in vivo antitumor efficacy and unique in vitro cytotoxicity profiles.合成具有体内抗肿瘤活性和独特体外细胞毒性特征的唑桥联双核铂(II)配合物。
Metallomics. 2013 May;5(5):461-8. doi: 10.1039/c3mt00040k. Epub 2013 Apr 23.
3
Highly efficient DNA compaction mediated by an in vivo antitumor-active tetrazolato-bridged dinuclear platinum(II) complex.一种具有体内抗肿瘤活性的四唑桥联双核铂(II)配合物介导的高效 DNA 压缩。
Inorg Chem. 2011 Nov 21;50(22):11729-35. doi: 10.1021/ic2017165. Epub 2011 Oct 17.
4
Highly efficient uptake into cisplatin-resistant cells and the isomerization upon coordinative DNA binding of anticancer tetrazolato-bridged dinuclear platinum(II) complexes.抗癌四唑桥联双核铂(II)配合物对顺铂耐药细胞的高效摄取及其与DNA配位结合后的异构化作用
Metallomics. 2015 Nov;7(11):1488-96. doi: 10.1039/c5mt00174a. Epub 2015 Sep 22.
5
Second- and higher-order structural changes of DNA induced by antitumor-active tetrazolato-bridged dinuclear platinum(II) complexes with different types of 5-substituent.具有不同 5-取代基的抗肿瘤活性四唑桥联双核铂(II)配合物诱导的 DNA 的二级和更高阶结构变化。
J Inorg Biochem. 2013 Oct;127:169-74. doi: 10.1016/j.jinorgbio.2013.05.004. Epub 2013 May 9.
6
Kinetic analysis of and platinum(II) migration in the reactions of tetrazolato-bridged dinuclear platinum(II) complexes with nucleotides.含四唑桥联双核铂(II)配合物与核苷酸反应中的动力学分析及铂(II)迁移
J Inorg Biochem. 2017 Dec;177:359-367. doi: 10.1016/j.jinorgbio.2017.08.010. Epub 2017 Aug 25.
7
Synthesis and structure-activity relationships of tetrazolato-bridged dinuclear platinum(II) complexes: A small modification at tetrazole C5 markedly influences the in vivo antitumor efficacy.四唑桥联双核铂(II)配合物的合成及构效关系:四唑 C5 位的微小修饰显著影响体内抗肿瘤活性。
J Inorg Biochem. 2019 Mar;192:82-86. doi: 10.1016/j.jinorgbio.2018.12.009. Epub 2018 Dec 23.
8
An in vivo highly antitumor-active tetrazolato-bridged dinuclear platinum(II) complex largely circumvents in vitro cisplatin resistance: two linkage isomers yield the same product upon reaction with 9-ethylguanine but exhibit different cytotoxic profiles.一种体内具有高抗肿瘤活性的四唑桥联双核铂(II)配合物在很大程度上规避了体外顺铂耐药性:两种连接异构体与 9-乙基鸟嘌呤反应生成相同产物,但表现出不同的细胞毒性特征。
Metallomics. 2012 Jul;4(7):686-92. doi: 10.1039/c2mt20026k. Epub 2012 Apr 3.
9
Introduction of Fluorine into Antitumor-Active Dinuclear Platinum(II) Complexes Leads to Modulation of Antitumor Activity in Mice.氟原子引入抗肿瘤活性双核铂(II)配合物导致其在小鼠体内抗肿瘤活性的调节。
Inorg Chem. 2022 Aug 8;61(31):12155-12164. doi: 10.1021/acs.inorgchem.2c01126. Epub 2022 Jul 25.
10
[Drug discovery research in in-vivo antitumor-active azolato-bridged dinuclear Pt(II) complexes].[体内抗肿瘤活性唑桥联双核铂(II)配合物的药物发现研究]
Yakugaku Zasshi. 2012;132(3):253-9. doi: 10.1248/yakushi.132.253.

引用本文的文献

1
Azolato-Bridged Dinuclear Platinum(II) Complexes Exhibit Androgen Receptor-Mediated Anti-Prostate Cancer Activity.唑桥联双核铂(II)配合物表现出雄激素受体介导的抗前列腺癌活性。
Inorg Chem. 2024 Nov 4;63(44):20951-20963. doi: 10.1021/acs.inorgchem.4c01093. Epub 2024 Sep 11.
2
Data on synthesis and structure-activity relationships of tetrazolato-bridged dinuclear platinum(II) complexes.四唑桥联双核铂(II)配合物的合成及构效关系数据。
Data Brief. 2021 Dec 10;40:107697. doi: 10.1016/j.dib.2021.107697. eCollection 2022 Feb.
3
Different Effects of Cisplatin and Transplatin on the Higher-Order Structure of DNA and Gene Expression.
顺铂和反式铂对 DNA 高级结构和基因表达的不同影响。
Int J Mol Sci. 2019 Dec 19;21(1):34. doi: 10.3390/ijms21010034.